Clinical Trial Update: Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup [Phase 1]

View source ↗

Summary

Phase 1 crossover bioequivalence study comparing SCMC-Lys Salt powder to SCMC-Lys Salt syrup in bronchitis; results have been posted after completion of the BE …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• SCMC-Lys Salt (SCMC-Lys Salt)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Bronchitis | Phase 1 | Status: COMPLETED | Results posted: 2024-11-18